Filtering specifically for breast cancer datasets that included the recurrence risk during the first year following treatment, we found significant correlations between recurrence and the expression of negative (GSK3β) or positive (TCF4) regulators of Wnt/β-catenin signaling (Fig. 6C). The gene discussed is GSK3B; the disease is breast cancer.